UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038989
Receipt number R000044457
Scientific Title Ventilation setting to minimize physiological dead space with volumetric capnography
Date of disclosure of the study information 2020/01/10
Last modified on 2021/12/27 12:59:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Ventilation setting to minimize physiological dead space with volumetric capnography

Acronym

Ventilation setting to minimize physiological dead space with volumetric capnography

Scientific Title

Ventilation setting to minimize physiological dead space with volumetric capnography

Scientific Title:Acronym

Ventilation setting to minimize physiological dead space with volumetric capnography

Region

Japan


Condition

Condition

Anaesthesia undergoing robot-assisted laparoscopic radical prostatectomy

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To minimize physiological dead space using volumetric capnography,in which shunt dead space and alveolar dead space would indicate moderate I:E ratio.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

physiological dead space during ventilation

Key secondary outcomes

Airway, Alveolar, shunt dead space, and functional residual capacity, Total PEEP, Auto PEEP during ventilation


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Using respiratory ventilation (Engstrom Caredtation, GE Healthcare), interventions start after Trendelenburg position and pneumoperitoneum were established. Using PC-VG mode, the target volume is set to 6 -8 ml/kg of ideal body weight. Respiratory rate is set to 12 bpm.

Setting 1; I:Eratio of 1:2, PEEP of 5 cmH2O.

Interventions/Control_2

Setting 2; I:E ratio of 2:1, PEEP of 0 cmH2O

Interventions/Control_3

Setting 3; I:E ratio of 3:1, PEEP of 0 cmH2O

Interventions/Control_4

Setting 4; I:E ratio of 4:1, PEEP of 0 cmH2O

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >=

Gender

Male

Key inclusion criteria

ASA PS 1 to 2 scheduled for robot-assisted laparoscopic radical prostatectomy were considered eligible.
FVC % predicted < 100%

Key exclusion criteria

The exclusion criteria were as follows; ASA physical status 3 to 5, a history of COPD, pneumothorax and previous lung surgery.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Go
Middle name
Last name Hirabayashi

Organization

Mizonokuchi Hospital, Teikyo University School of Medicine

Division name

Anesthesiology

Zip code

213-8507

Address

5-1-1 Futako Takatsu-ku kKawasaki Kanagawa

TEL

044-844-3333

Email

goh@med.teikyo-u.ac.jp


Public contact

Name of contact person

1st name Go
Middle name
Last name Hirabayashi

Organization

5-1-1 Futako Takatsu-ku kKawasaki Kanagawa

Division name

Anesthesiology

Zip code

213-8507

Address

5-1-1 Futako Takatsu-ku kKawasaki Kanagawa

TEL

044-844-3333

Homepage URL


Email

goh@med.teikyo-u.ac.jp


Sponsor or person

Institute

Teikyo University

School of Medicine

Mizonokuchi Hospital

Institute

Department

Personal name



Funding Source

Organization

Mizonokuchi Hospital, Teikyo University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teikyo University School of Medicine

Address

2-11-1 Kaga Itabashi Tokyo

Tel

03-3964-9358

Email

turb-office@teikyo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

帝京大学医学部附属溝口病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 06 Day

Date of IRB

2019 Year 04 Month 15 Day

Anticipated trial start date

2019 Year 06 Month 15 Day

Last follow-up date

2020 Year 07 Month 30 Day

Date of closure to data entry

2020 Year 08 Month 31 Day

Date trial data considered complete

2020 Year 09 Month 30 Day

Date analysis concluded

2021 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 12 Month 25 Day

Last modified on

2021 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044457


Research Plan
Registered date File name
2021/07/16 2020年度研究計画書.docx

Research case data specifications
Registered date File name
2021/07/16 データ仕様書.xlsx

Research case data
Registered date File name
2021/07/16 解析データ.xlsx